New insider activity at Stryker ( (SYK) ) has taken place on August 21, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Robert S Fletcher, the Vice President and Chief Legal Officer of Stryker, has recently sold 1,785 shares of the company’s stock. This transaction was valued at $701,629, highlighting a significant financial move within the company.
Recent Updates on SYK stock
Stryker Corp’s recent developments have led to several price target increases by analysts, driven by the company’s strong Q2 earnings report. The earnings call highlighted robust sales growth, particularly in the U.S. market, and successful product launches, despite challenges such as supply chain issues and tariff impacts. Stryker reported a 10.2% organic sales growth and an 11.4% increase in adjusted EPS, with notable performance in the MedSurg and Neurotechnology segments. The company’s strong market position and effective strategies have contributed to its positive outlook, resulting in raised guidance for full-year 2025. Analysts have responded to these developments by adjusting price targets upwards, reflecting confidence in Stryker’s growth trajectory and market strategies.
Spark’s Take on SYK Stock
According to Spark, TipRanks’ AI Analyst, SYK is a Outperform.
Stryker’s overall stock score is driven by its strong financial performance and positive earnings call, which highlight robust sales growth and a positive outlook. However, the high valuation and mixed technical indicators temper the score, suggesting some caution for potential investors.
To see Spark’s full report on SYK stock, click here.
More about Stryker
YTD Price Performance: 9.32%
Average Trading Volume: 1,244,085
Technical Sentiment Signal: Strong Buy
Current Market Cap: $149.1B